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Hyperbaric oxygenation as an adjuvant therapy  
for traumatic brain injury: a review of literature
Abstract
In recent years significant amount of data have been published in the 
filed of hyperbaric oxygenation (HBO) and traumatic brain injury (TBI). 
The main rational for the research in this field is that in TBI patients with 
the existence of dormant neural tissues that maintain cellular homeostasis 
but are unable to participate in neurotransmission, the addition of HBO 
provides a favourable environment by which neuronal reactivation can be 
achieved. As hyperbaric oxygen therapy is not all-or-nothing phenomena 
and the consequences of TBI can vary from mild to moderate and severe, it 
is important to evaluate each TBI patient before referring him/her to hyper-
baric oxygen therapy (HBOT). Reports from the clinical trial that were 
investigating the effects of HBO on severe TBI show promising results. For 
example, significant reduction in mortality rates and improvement in fa-
vourable neurological outcomes were reported. However, conflicting results 
have been reported from trials that investigated the effects of HBO on mild 
and moderate TBI. The results from the experimental studies indicate that 
HBO can preserve mitochondrial function, reduce apoptosis and neuroin-
flammation and promote neuronal plasticity. Therefore, conducting of 
methodologically-based multicentric clinical trials is necessary to determine 
proper guidelines for inclusion of TBI patients in HBOT. As many reports 
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have stated that even a few exposures to HBO can contribute 
to the recovery process, future research must be aimed at es-
tablishing most effective HBO protocol for TBI patients.
BACKGROUND
Traumatic brain injury
Considering the fact that the consequences of trau-matic brain injury (TBI) can persist for many years, 
included for life, TBI can be considered as a chronic dis-
ease (1-4). The acute phase is a process that consists of at 
least two stages. The first is often referred to as a primary 
injury. It occurs momentarily after the initial mechanical 
impact and in most of the TBI patients this stage is over 
before they are admitted to the medical institution. The 
severity of the primary injury depends on the location of 
the affected brain region as well as duration and intensity 
of the inflicted force (3). Biochemical and metabolic pro-
cesses that follow afterwards in hours, days and some-
times even weeks are referred to as the secondary injury 
(4). Formation of the glial scar tissue marks the transition 
of the healing process into the chronic phase (5). Conse-
quences of the TBI can vary from mild, moderate to se-
vere and they can persist for a lifetime. They pose a great 
personal and a wider socio-economical problem (6).
At site of the primary impact a permanent neuronal 
loss can be often seen. This region is called the „core”. The 
surrounding regions, consisting of neuronal tissues that 
have not been directly exposed to trauma, are often ad-
dressed to as the „penumbra area”. Neurons inside this 
zone are at risk due to several reasons: impaired blood flow 
(limited or not at all), inflammation, development of oe-
dema, acidosis, and haemorrhage and they lose most of 
their connections with other neurons (7-9). Secondary 
degeneration can also progress into the surrounding intact 
regions of the brain. Compromised blood flow and insuf-
ficient oxygen supply leads to tissue hypoxia and the re-
sulting energy failure initiate a cascade of cellular events 
that culminates with neuronal cell apoptosis (10).
Most of the neuro-therapeutic strategies are directed 
towards the containment of the secondary processes and 
the preservation and reactivation of the penumbra area 
(11). The activity of glial cells is of tremendous importance 
in early stages of the healing process, but when the glial 
scar is formed it represents a barrier for the neuronal 
sprouting and reduces the ability of brain to re-establish 
new functional neuronal circuits (12).
Until now universal therapeutic strategy and a single 
medicament have not been found that are able to affect 
all the processes that are occurring during TBI and di-
minish all of its consequences. Considering the fact that 
energy metabolism in the brain is based upon aerobic 
processes, it is only logical to assume that in pathological 
conditions such as TBI, increasing oxygen supply to the 
traumatized brain tissue should lead to better neurologi-
cal outcome. The main rational for implementation of 
hyperbaric oxygen therapy (HBOT) in treatment strate-
gies aimed to improving the consequences of TBI is that 
in TBI patients addition of oxygen under hyperbaric con-
ditions provides a favourable environment by which neu-
ronal reactivation can be achieved. Unfortunately, even 
the most sophisticated diagnostic methods are not capable 
to distinguish with absolute certainty whether the areas 
that are appear as gliosis may actually be viable nerve tis-
sue that can be reactivated. Single photon emission com-
puted tomography (SPECT) appears to be a most suitable 
diagnostic method for this task (13).
Hyperbaric oxygenation mechanism  
of action
Hyperbaric oxygenation (HBO) or hyperbaric oxygen 
therapy (HBOT) is the therapeutic modality in which a 
patient breathes 100% oxygen intermittently, while the 
pressure of the treatment chamber is increased to more 
than one atmospheric pressure (14). HBO can be used to 
obtain 100% saturation of haemoglobin and to signifi-
cantly elevate the volume of physically dissolved oxygen 
fraction in blood plasma. HBO also has anti-inflamma-
tory activity and promotes neo-angiogenesis. HBO has 
become the definitive therapy for patients with decom-
pression illness, air or gas embolism, carbon monoxide 
poisoning, gas gangrene and compartment syndrome, 
intracranial abscess, osteomyelitis, delayed radiation in-
jury, skin grafts and flaps, and is a widely accepted treat-
ment for wound healing and burns (15-16).
The exact mechanisms by which HBO exerts its posi-
tive effects are still lacking. The rational for application of 
HBO after TBI is that HBO might produce a marked 
elevation in arterial blood oxygen partial pressures and 
content to combat local anoxia and the resulting energy 
failure, which together initiate a cascade of cellular events 
that culminate in cell death. In comparison to the normo-
baric conditions increased oxygen supply under hyper-
baric conditions make easier diffusion of oxygen into the 
damaged tissue and also for longer distance (17). It is as-
sumed that relief of hypoxia and cerebral oedema (18), 
improvement of microcirculation with decrease of intra-
cranial pressure (19), and improvement of cerebral me-
tabolism (20) are also among the positive effects of HBO.
Over the years several systematic reviews have con-
cluded that the evidence for the use of HBO for treatment 
of TBI is insufficient to prove effectiveness or ineffective-
ness, and that more high-quality studies and multicenter 
prospective randomized clinical trials are needed (21-24). 
In recent years a substantial amount of new data has been 
published indicating that HBO can interfere with the 
processes that follow TBI and moderate its consequences. 
Accordingly in this review we have focused our attention 
on finding publications that evaluate this topic in the time 
period from the year 2008 up to today.
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All of the data used in this review were obtained from 
studies using either human or animal subjects, which 
could be found in Pub-Med, EMBASE, and the Co-
chrane Library data base. Combinations of the following 
keywords were used for the search: traumatic brain in-
jury, hyperbaric oxygen therapy, hyperbaric research, 
normobaric hyperoxia, adjuvant therapy, cerebral blood 
flow, cerebral metabolism, intracranial pressure, apopto-
sis, oxidative stress and oxygen toxicity. All of the studies 
described here, were reviewed by a local ethics committee 
and were conducted in accordance to the Declaration of 
Helsinki (1975) and with recommendations given in NIH 
Guide for the Care and Use of Laboratory Animals (NIH 
publication No. 85-23).
Clinical studies
The continuous researches conducted by Sarah Rock-
sworld and Gaylan Rocksworld alongside with their col-
leagues will be regarded in the future as milestone studies 
with respect to implementation of HBO in treatment of 
severe traumatic brain injury (25-30). In their paper pub-
lished in Journal of Neurosurgery they presented the results 
of a first prospective, randomized phase II clinical trial 
aimed at evaluating the effects of combined hyperbaric 
and normobaric hyperoxia (NBH) in severe TBI (25). 
Forty-two patients were included in this trial. Research 
paradigm examined the comparison between combined 
HBO/NBH treatments with standard care. Twenty pa-
tients received the combined HBO/NBH treatment, 
which consisted of 100% oxygen for 60 minutes at 1.5 
atmospheres absolute (ATA), followed by 3 hours at 1.0 
ATA. The control treatment for 22 patients was standard 
care. The first HBO/NBH treatment was administered as 
soon as the entry criteria were met and the patient’s condi-
tion was clinically stable. Subsequent treatments were 
given every 24 hours. Patients received 3 consecutive 
treatments unless they became brain dead or were consis-
tently able to follow commands. HBO treatment was 
conducted in multiplace as well in monoplace chamber. 
There were no statistically significant differences in any 
of the variables between the patients using the mono-
place chamber and those using the multiplace chamber. 
From this study they concluded that in comparison to 
standard care combined HBO/NHB treatments signifi-
cantly improve markers of oxidative metabolism in rela-
tively uninjured brain as well as in pericontusional tissue, 
reduce intracranial hypertension, and diminish the pres-
ence of markers of cerebral toxicity. More importantly 
they established that mortality rate was statistically sig-
nificantly lower (p = 0.0482, 26% reduction), in the com-
bined HBO/NHB group (16% mortality rate) as com-
pared to the control group (42% mortality rate). Six 
month after the traumatic incident, favourable outcome 
as measured by the sliding dichotomized Glasgow Coma 
Scale (GCS) was observed in 14 out of 19 patients from 
the HBO/NHB group (74%) and in 8 out of 21 patients 
from the control group (38%).
The use of combined HBO and NBH therapy was 
based on the results of their previous study (26). In this 
study sixty nine TBI patients were within 24 hours of 
injury, prospectively randomized in to 3 groups: first 
group received HBO therapy 100% oxygen at 1.5 ATA 
for 60 minutes, second NBH group received 100% oxy-
gen at 1 ATA for 3 hours, and the control group which 
have received the standard care. Based on the results, they 
concluded that HBO has a more robust post treatment 
effect compared to NHB on oxidative cerebral metabo-
lism. Very important finding was that no signs of pulmo-
nary or cerebral oxygen toxicity were registered. The au-
thors concluded that HBO treatment for severe TBI is not 
all-or-nothing phenomena and that development of ben-
eficial effects is a gradual process.
For every therapeutic agent adequate time frame for 
application is of the most importance. Considering the 
fact that sever TBI represent life threatening conditions 
and that patients stabilization is a primary goal, one can 
not expect that such patient will be in a short time period 
transfer to hyperbaric unite. Therefore it is important to 
investigate whether delayed application of HBO can exert 
positive effect on the recovery process.
Lin et al. have reported that sub acute patients with 
TBI can benefit from HBO with none or minimal side 
effects (31). In this study they have randomly organized 
22 patients who received 100% oxygen at 2 ATA for 2 
hours, and the other 22 patients with corresponding con-
ditions into the control group that received standard care. 
The clinical conditions of the patients were evaluated with 
the Glasgow Coma Scale and Glasgow Outcome Scale 
(GOS) before and 3 to 6 months after HBOT. The GCS 
of the HBO group was improved from 11.1 to 13.5 in 
average, and from 10.4 to 11.5 (p < 0.05) for control 
group. Among those patients with GOS = 4 before the 
HBOT, significant GOS improvement was observed in 
the HBOT group 6 months after the HBOT.
Sahni et al. have conducted a retrospective analysis of 
TBI patients that were subjected to HBO (32). Although 
the authors have concluded that the results from their 
study must be interpreted cautiously, we must address to 
them as a good starting point for future investigations. 
The test group consisted of 20 patients that were within 
the six months after the TBI subjected to HBO. Patients 
from the test group have all received at least 30 HBO 
sessions, at 1.5 ATA, for 60 minutes, in multiplace cham-
ber (via oxygen mask, or T-tube), once daily in addition 
to standard care. Other 20 patients with corresponding 
clinical characteristics were given only standard treat-
ment. Assessment using the Disability Rating Scale 
(DRS) showed a significant improvement in the vegeta-
tive state among the patients that have received HBO. 
Thus the patients in the vegetative state (DRS Score 22-
24) showed maximum improvement and the percentage 
dropped from 45% to 5% in test group compared to a 
reduction from 45% to only 25% in the control group. 
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The improvement in cognitive functions assessed with 
Ranchos Los Amigos Scale (RLA) was more prominent 
in test group, from which 90% patients had a score of ≤ 
3 before starting HBO treatment and that was reduced 
to 35% after treatment. In control group 95% of patients 
had a similar score before treatment and these was re-
duced to 60 % after standard treatment.
Hardy et al. have presented a single case study of the 
therapeutic potential of HBO on chronic brain injury (33). 
A 54-year old man was one year after sustaining severe TBI 
exposed to 100% oxygen, at 2.0 ATA, for 60 minutes. 
Initial treatment consisted of 20 exposures, after which 
improvement in sensory motor functions were observed. 
Nevertheless, these positive shifts diminished in the fol-
lowing year, but were reinstated with an additional series 
of 60 HBO exposures. Neuropsychological improvements 
were also observed after the second treatment series.
Case reports in which positive effects of HBOT on 
mild TBI are also reported (34). However, according to 
the authors of the first single center, double blind, sham 
controlled prospective trial in which the effects of HBOT 
on symptoms after mild TBI were investigated, obtained 
results were not promising (35). At the U.S. Air Forse 
School of Aerospace Medicine, in 50 military service 
members, who had sustained at least one combat-related 
mild TBI, the effects of hyperbaric oxygen on post con-
cussion symptoms were investigated. Participants were 
organized in two groups. Sham control group was ex-
posed to roam air at 1.3 ATA, and experimental group 
was exposed to 100% oxygen at 2.4 ATA. Over eight-
week period each subject received 30 sessions. Individual 
and total symptoms scores on Immediate Post-Concus-
sion Assessment and Cognitive Testing (ImPACT) and 
composite scores on Post-traumatic Disorder Check List-
Military Version (PCL-M) were measured just prior to 
intervention and 6 weeks after completion of interven-
tion. Difference testing of post-intervention means be-
tween the sham-control and HBO group revealed no 
significant differences on the PCL-M composite score (t 
= -0.205, p = 0.84) or on the ImPACT total score (t = 
-0.943, p = 0.35). PCL-M composite scores and ImPACT 
total scores for sham control and HBO groups revealed 
significant improvement over the course of the study for 
both the sham control group (t = 3.76, p = 0.001) and 
the HBO group (t = 3.90, p = 0.001), demonstrating no 
significant HBO effect. Paired t-test results revealed 10 
ImPACT scale scores in the sham control group improved 
from pre- to post-testing, whereas two scale scores sig-
nificantly improved in the HBO group. One PCL-M 
measure improved from pre- to post-testing in both 
groups. Based on the results the authors have concluder 
that that HBO at 2.4 ATA pressure had no effect on post-
concussive symptoms after mild TBI.
We must certainly compliment the authors for orga-
nizing and completing this complex study. Unfortunate-
ly we must also point out serious objections to the study 
design as other colleagues have already stated (36, 37). It 
has been pointed out that in this study the dose responsive 
effect of HBO was not taken under the consideration and 
that sham control group should be considered to be also 
a treatment group and that the conclusion of the authors 
that HBO does not exerts any positive effective on mild 
brain injury is at this point an overstatement.
Researches conducted by Harch and his colleagues 
have also focused the attention on this topic (38). The first 
phase study of low pressure HBOT for blast induced post 
concussion syndrome (PCS) and post traumatic stress 
disorder (PTSD) was conducted on sixteen military sub-
jects with chronic mild to moderate traumatic brain in-
jury. The HBO protocol consisted of 100% oxygen at 1.5 
ATA for 60 min, 40 sessions in 30 days. According to the 
obtained data they have concluded that significant im-
provements occurred in symptoms, abnormal physical 
exam findings, cognitive testing, and quality-of-life mea-
surements, with concomitant significant improvements 
in results from the SPECT imaging.
Recently published results of Boussi-Gross et al. have 
demonstrated the effectiveness of HBOT in improving 
brain function and quality of life in mild TBI patients 
suffering from chronic neurocognitive impairments (39). 
The trial population included 56 mild TBI patients that 
within one to five years after sustaining brain injury still 
hade prolonged post concussion syndrome. The HBO ef-
fects were evaluated by means of prospective, randomized, 
crossover controlled trial. The patients were randomly as-
signed to treated or crossover groups. Patients in the treat-
ed group were evaluated at baseline and following 40 HBO 
sessions. Patients in the crossover group were evaluated 
three times: at baseline, following a two-month control 
period of no treatment, and following subsequent two 
months of 40 HBO sessions. The HBO protocol included 
40 treatment sessions, five sessions per week, 60 minutes 
each, with 100% oxygen at 1.5 ATA. ‘‘Mindstreams’’ was 
used for cognitive evaluations, quality of life was evaluated 
by the EQ-5D questionnaire, and changes in brain activ-
ity were assessed by SPECT imaging. Significant improve-
ments were demonstrated in cognitive function and qual-
ity of life in both groups following HBOT but no 
significant improvement was observed following the con-
trol period. SPECT imaging revealed elevated brain activ-
ity which was in good agreement with the cognitive im-
provements. Their conclusions were that HBOT can 
induce neuroplasticity leading to repair of chronically im-
paired brain functions and improved quality of life in mild 
TBI patients with prolonged PCS at late chronic stage.
These results are raising the most significant question 
and that is how to properly select TBI patients for enrol-
ment in HBO treatment. Patient whit the existence of 
„idle” neurons in other words „dormant” neural tissue that 
maintains cellular homeostasis but is unable to participate 
in neurotransmission is, as it was correctly stated in these 
studies, the one that can expect the most benefit from 
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HBOT. The main pathology in these cases involves diffuse 
brain injuries, which are hard to detect by anatomical im-
aging yet noticeable in metabolic imaging. Accordingly, 
the existence of the discrepancy between the results from 
the „metabolical” (such as SPECT scan) and „anatomical” 
(such as CT) imaging techniques should be focused upon, 
in an effort to properly determine the possibility for achiev-
ing the most beneficial effects of HBOT in TBI patients.
At this point it must be stated that in conducted stud-
ies the development of significant adverse effects, especial 
in terms of oxidative damage in TBI patients who were 
exposed to hyperbaric oxygen were not registered. Cases 
of sporadic middle ear barotraumas and reversible bron-
chospasm were reported.
Undergoing research regarding the effects of hyper-
baric oxygen on post-concussion syndrome organized by 
The Department of Defence of United States of America, 
in collaboration with the Department of Veterans Affairs 
will, as they have stated comprehensively examine the 
potential for the use of HBO in treatment of mild TBI 
(40). They are planning four randomized controlled trials 
which will enrol a total of 242 service members with post-
concussion syndrome. Participants will be exposed to a 
range of control, sham and HBO conditions for 40 ses-
sions over a period of eight to eleven weeks. Compression 
pressures will range from 1.2 ATA (sham) to 2.4 ATA, 
and oxygen concentration will range from room air (sham 
and control) to 100%. Outcomes measures will include 
both subjective and objective measures performed at base-
line, at exposure completion, and at three to twelve 
months’ follow-up. As they have stated, this integrated 
program of clinical trials investigating the efficacy of 
HBOT in service members with persistent symptoms fol-
lowing mild TBI exposure will be important to define 
practice guidelines and, if needed, for the development of 
definitive clinical trials in this population.
ExpERImENTAL STUDIES
One can only speculate whether the same results as the 
ones obtained from the studies conducted on animal 
models, can be expected in studies conducted on human 
population. But still animal models of TBI can give us 
very useful information and present guidelines for future 
research design in humans. Since impaired control of lo-
comotor functions is one of the most severe consequenc-
es of TBI, many animal studies are directed to test wheth-
er HBOT can contribute to this vitally important aspect 
of the recovery process.
Lim et al. have reported that implementation of HBO 
can contribute to the recovery of motor skills in rats after 
TBI, and that potential underlining mechanism is at-
tenuation of neuroinflammation response (41). Fluid per-
cussion technique was used to inflict TBI in rats. Hyper-
baric protocol consisted of a single exposure to 100% 
oxygen, at 2.0 ATA, one hour or eight hours subsequent 
to TBI. Neurobehavioral rehabilitation was evaluated by 
the inclined plane test on the 72 hour after TBI. The fol-
lowing parameters were also evaluated: infarction area, 
neuronal apoptosis, microglial cell aggregation count, and 
tumor necrosis factor-alpha (TNF-a) expression in mi-
croglia cell. They have registered that regardless of wheth-
er the animals were treated with HBO one or eight hours 
after TBI they have exhibited significantly better scores 
in behavioural tests in comparison to the control animals. 
Cerebral infarction areas of the rats after TBI were sig-
nificantly attenuated by HBO therapy compared with the 
controls. TBI induced microglial activation, TNF-a ex-
pression, and neuronal apoptosis were also significantly 
reduced by HBO therapy. Their results demonstrate that 
HBO treatment during the acute phase of TBI can posses 
a neuroprotective effect and that attenuation of microg-
liosis and reduction of proinflammatory cytokine TNF-a 
expression are among the underlining mechanisms.
In our studies we have used two different models of 
experimental TBI. In order to examine the effects of 
HBO upon recovery of motor function we have used suc-
tion ablation model (SCA), and in an effort to compre-
hend underlining mechanisms we have used cortical stab 
injury (CSI) model of TBI (42-44). Suction ablation 
model of TBI inflicts unilateral highly reproducible le-
sions of hindlimb sensorimotor cortex, of uniform size 
and depth (45). The first exposure to HBO occurred when 
all the animals have regained consciousness five hours 
after the operation. HBO protocol consisted of 60 minute 
exposure to 100% oxygen at 2.5 ATA, which was contin-
ued once a day for 10 consecutive days. For evaluation of 
the recovery process beam walking and grip strength be-
havioural testing were conducted. The effects of SCA and 
HBOT on expression profiles of markers of synaptic plas-
ticity, growth-associated protein 43 and protein involved 
in synapse formation - synaptophysin, were detected us-
ing immunohistochemitry. We have registered that 
HBOT can improve locomotor ability in rats after TBI 
and that intensified neuronal plasticity in terms of en-
hanced axonal sprouting and synapse remodelling are 
among the underlining mechanisms.
As the role of reactive oxygen species (ROS) in induc-
tion of neuronal damage and prevention of neuronal plas-
ticity is becoming more apparent, a great interest was put 
on investigation of the effect of HBOT on parameters of 
antioxidant defence mechanisms after TBI (46, 47).
Studies conducted by Palzur, Voldavsky and their col-
leagues have clarify many underlining mechanisms in 
these field (48-52). Most of their research was conducted 
on dynamic cortical deformation model (DCD) of TBI. 
HBO protocol that they have used consisted of two con-
secutive 45 minute sessions, during which 100% oxygen 
was administered at 2.8 ATA. First HBO exposure start-
ed 3 hours after the injury and second one 24 hours later. 
Theirs earlier research have shown that HBO can reduce 
secondary neuronal degeneration and can attenuate apop-
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tosis after experimental TBI (48). They have also reported 
that HBO can reduce neuroinflammation after TBI (49). 
The preservation of mitochondrial function and integrity, 
as well as the reduction of oxidative damage, are accord-
ing to their results among the most important effect of 
HBO in the recovery process after TBI (50). Therefore, 
they have proven the most commonly used rational for 
the research in the field of implementation of HBO in 
treatment strategies intentional to improve the conse-
quences of TBI, and that is that increased intracellular 
oxygen bio-availability can both contribute to preserve 
mitochondrial integrity and reduce the activation of the 
mitochondrial pathway of apoptosis. Among the animals 
that underwent HBO protocol there was a significant at-
tenuation of the impact of DCD over perilesional neu-
rons, characterized by significantly higher cell counts and 
denser axonal network. In mitochondria isolated from 
injured brain tissue, HBO substantially reversed the loss 
of mitochondrial transmembrane potential. Their reports 
are stating that HBO can selectively affect the intrinsic 
pathway of apoptosis (51, 52).
Zhou et al. have also showed that protection of mito-
chondrial function after TBI is one of the most important 
effects of HBOT (53). They have reported that the im-
provement of cognitive functions was registered in rats 
that were exposed to HBO. They have used lateral fluid 
percussion model of TBI and a variety of both HBO and 
NBO protocols in their research.
Our group has also observed that reduction of oxida-
tive stress can be achieved by application of HBOT after 
TBI (43). Cortical stab injury model was used in this 
research. HBO protocol consisted of 60 minute exposure 
to 100% oxygen at 2.5 ATA, once a day for 3 or 10 con-
secutive days. Pattern of superoxide dismutase 2 (SOD2) 
expression and cellular localization were analysed using 
Real-time PCR, Western Blot and double-label fluores-
cence immunohistochemistry. Neurons undergoing de-
generation were visualized with Fluoro-Jade. Our results 
have indicated that injury induced significant transient 
increase in SOD2 protein levels at day 3 post injury, 
which was followed by reduction towards control levels at 
post-injury day 10. At the same time points, mRNA lev-
els for SOD2 in injured cortex were down-regulated. Ex-
posure to HBO for 3 days considerably down-regulated 
SOD2 protein levels in the injured cortex, while after 10 
days of HBOT an up-regulation of SOD2 was observed. 
HBOT significantly increased mRNA levels for SOD2 at 
both time points compared to corresponding group. 
Double immunofluorescence staining revealed that 3 days 
after the TBI up-regulation of SOD2 was mostly due to 
increased expression in reactive astrocytes surrounding 
the lesion site. HBOT attenuated SOD2 expression both 
in neuronal and astroglial cells. According to Fluoro-Jade 
B labelling, HBOT decreased the number of degenerating 
neurons in injured cortex. So, we have concluded that 
HBOT can moderate the effect of oxidative stress after 
TBI by influencing expression pattern of SOD2 and 
thereby reduces neuronal degeneration. Our preliminary 
data are showing that HBO can also interfere with the 
activity of glial cells after TBI, especially astorcytes and 
microglia, so in the future we will focus to investigate that 
in more details (44).
In their complex study Wang et al. (54) have used Fee-
ney model of TBI (55). The right cerebral cortex of rats was 
injured by the impact of a 20-g object dropped from a 
predetermined height. Neurological behaviour 
score, brain water content, neuronal loss in the hippocam-
pus, and cell apoptosis in the brain tissue surrounding the 
primary  injury  site were examined in order to deter-
mine brain damage severity. In an effort to determine 
most effective time frame for the application of HBO, 
animals were exposed to a single treatment with 100% 
oxygen, at 3 ATA, for 60 minutes, at the following time 
points: 3, 6, 12, 24, 48 and 72 hours after TBI. Three and 
six hours after TBI, HBO-treated rats displayed a sig-
nificant reduction in brain damage. However, by 12 hours 
after TBI, the efficacy of HBO treatment was consider-
ably attenuated. Furthermore, at 24, 48, and 72 hours 
after TBI, a singl HBO treatment did not show any no-
table effects. The following experiments evaluated the 
effects of multiple exposures to HBO (three or five times 
in all) that started at the same time points. The results 
have shown that even when implementation of HBO 
started 48 hours after TBI it can remarkably reduced neu-
rological deficit scores and the loss of neurons in the hip-
pocampus. The overall most prominent beneficial  ef-
fects were registered after a single treatment at 6 hours 
after TBI. Based upon these results authors have con-
cluded that within 12 hours after TBI even a single 
HBO treatment could alleviate brain damage and that 
multiple HBO treatments have the possibility to extend 
the post-TBI delivery time window. This research group 
has also reported that HBO can influence the activity of 
glial cells, oxidative status and inflammatory processes 
after TBI (56, 57). Unfortunately for us these papers were 
in extenso published in Chinese language.
Several studies have used the magnetic resonance im-
aging (MRI) to monitor the effects of HBOT on experi-
mental TBI. Based on the analysis of their results Wei et 
al. have concluded that 10 HBO exposures could improve 
the impaired blood brain barrier and cytotoxic oedema in 
rabbits after TBI (58). On the other hand, Voigt et al. 
have shown that even a single exposure to hyperbaric ox-
ygen starting 1 h after impact injury significantly attenu-
ated lesion growth and had long-lasting neuroprotective 
effects on the contused brain and its penumbra (59). Har-
cha et al. have demonstrated that the 40-day series of 80 
low pressure HBOT can improve behavioural and neu-
robiological outcome in rats after unilateral focal cortical 
contusion (60). They have registered an increase in con-
tused vascular density which was associated with im-
provement in cognitive functions.
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Recent publication by Chor et al. has indicated that 
the addition of inert gases to HBO sessions, especially 
argon or xenon which show neuroprotective experimental 
effects, may provide an additional improvement of cere-
bral lesions (61).
CONCLUSION
Our opinion is that the critical amount of data have 
been published during recent years that are justifying fu-
ture clinical trials in the filed of hyperbaric oxygenation 
and traumatic brain injury. Further multicentric studies 
must be strictly methodologically organized in order to 
come up with adequate answers to the following ques-
tions: how to make a proper selection among TBI patients 
for inclusion in hyperbaric oxygen therapy, when to start 
with HBO exposures after TBI, which pressure to apply, 
duration and the adequate number of sessions, and can 
the application of normobaric hyperoxia be sufficient 
enough to achieve positive neurological outcome after 
traumatic brain injury.
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